Profile and management of toxicity of selinexor and belantamab mafodotin for the treatment of triple class refractory multiple myeloma

Karun Neupane, Ahsan Wahab, Adeel Masood, Tehniat Faraz, Saman Bahram, Hamid Ehsan, Abdul Hannan, Faiz Anwer

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Profile and management of toxicity of selinexor and belantamab mafodotin for the treatment of triple class refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences